Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Anti-Cancer Drugs
|
August 17, 2013
Current clinical trials with polo-like kinase 1 inhibitors in solid tumors
Hyungshin Yim
Frontiers in Bioscience (Landmark Edition)
|
September 21, 2017
53BP1: A guardian for centrosomal integrity
Haeyoung Kim, Hyungshin Yim
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 23, 2015
The tumor suppressor protein p150(Sal2) in carcinogenesis
Chang Kyoo Sung, Hyungshin Yim
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2010
Cell division cycle 6, a mitotic substrate of polo-like kinase 1, regulates chromosomal segregation mediated by cyclin-dependent kinase 1 and separase
Hyungshin Yim, Raymond L Erikson
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
August 3, 2013
The accumulation of DNA repair defects is the molecular origin of carcinogenesis
Hyuk-Jin Cha, Hyungshin Yim
Archives of Pharmacal Research
|
December 14, 2016
Roles of SALL2 in tumorigenesis
Chang K Sung, Hyungshin Yim
Cell Cycle (Georgetown, Tex.)
|
April 27, 2011
Regulation of the final stage of mitosis by components of the pre-replicative complex and a polo kinase
Hyungshin Yim, Raymond L Erikson
Molecular and Cellular Biology
|
March 18, 2009
Polo-like kinase 1 depletion induces DNA damage in early S prior to caspase activation
Hyungshin Yim, Raymond L Erikson
Mutation Research. Reviews in Mutation Research
|
March 18, 2014
Plk1-targeted therapies in TP53- or RAS-mutated cancer
Hyungshin Yim, Raymond L Erikson
Archives of Pharmacal Research
|
July 30, 2020
CRISPR-mediated promoter de/methylation technologies for gene regulation
Chang K Sung, Hyungshin Yim
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Anti-Cancer Drugs
|
August 17, 2013
Current clinical trials with polo-like kinase 1 inhibitors in solid tumors
Hyungshin Yim
Frontiers in Bioscience (Landmark Edition)
|
September 21, 2017
53BP1: A guardian for centrosomal integrity
Haeyoung Kim, Hyungshin Yim
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 23, 2015
The tumor suppressor protein p150(Sal2) in carcinogenesis
Chang Kyoo Sung, Hyungshin Yim
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2010
Cell division cycle 6, a mitotic substrate of polo-like kinase 1, regulates chromosomal segregation mediated by cyclin-dependent kinase 1 and separase
Hyungshin Yim, Raymond L Erikson
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
August 3, 2013
The accumulation of DNA repair defects is the molecular origin of carcinogenesis
Hyuk-Jin Cha, Hyungshin Yim
Archives of Pharmacal Research
|
December 14, 2016
Roles of SALL2 in tumorigenesis
Chang K Sung, Hyungshin Yim
Cell Cycle (Georgetown, Tex.)
|
April 27, 2011
Regulation of the final stage of mitosis by components of the pre-replicative complex and a polo kinase
Hyungshin Yim, Raymond L Erikson
Molecular and Cellular Biology
|
March 18, 2009
Polo-like kinase 1 depletion induces DNA damage in early S prior to caspase activation
Hyungshin Yim, Raymond L Erikson
Mutation Research. Reviews in Mutation Research
|
March 18, 2014
Plk1-targeted therapies in TP53- or RAS-mutated cancer
Hyungshin Yim, Raymond L Erikson
Archives of Pharmacal Research
|
July 30, 2020
CRISPR-mediated promoter de/methylation technologies for gene regulation
Chang K Sung, Hyungshin Yim
Page
of 6